Skip to main content
Contact +1 (919) 234-1277

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Margetuximab Biosimilar – Anti-ERBB2, EGFR2, CD340 mAb – Research Grade

Isotype:
IgG1, kappa

$143.00

+ 143 loyalty points
Size
Clear
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery
Margetuximab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb - Research Grade

Margetuximab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb - Research Grade

Product name Margetuximab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb - Research Grade
Source CAS 1350624-75-7
Species Chimeric
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Margetuximab,MGAH-22,ERBB2, EGFR2, CD340,anti-ERBB2, EGFR2, CD340
Reference PX-TA1331
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody
Product name Margetuximab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb - Research Grade
Source CAS 1350624-75-7
Species Chimeric
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Margetuximab,MGAH-22,ERBB2, EGFR2, CD340,anti-ERBB2, EGFR2, CD340
Reference PX-TA1331
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody

General information on Anti-ERBB2/EGFR2/CD340[Homo sapiens] (Margetuximab) Monoclonal Antibody

Margetuximab is an Fc-engineered human/mouse chimeric anti-HER2 monoclonal antibody of isotype IgG1 kappa . Margetuximab targets the same epitope on the HER2 extracellular domain and hass the same activity as trastuzumab. However, margetuximab has a higher affinity for both CD16A variants and a weaker one to the inhibitory CD32B Fc receptor, thereby resulting in more efficient antibody-dependent cell-mediated cytotoxicity (ADCC) and higher efficacy compared to trastuzumab. Margetuximab has been marketed under the trade name Margenza.

There are no reviews yet.

Be the first to review “Margetuximab Biosimilar – Anti-ERBB2, EGFR2, CD340 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products